Results 181 to 190 of about 7,577 (211)
Self-reported health as a predictor of cardiometabolic multimorbidity in Chinese older adults: a national cross-sectional study. [PDF]
Bing S +5 more
europepmc +1 more source
Estimation of small dense low-density lipoprotein cholesterol and cardiometabolic multimorbidity risk in middle-aged and elderly Chinese: findings from a nationwide prospective cohort. [PDF]
Zhao Y, Huang W, Li W, Shi Z.
europepmc +1 more source
Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study [PDF]
AbstractAims The potential difference in the impacts of lifestyle factors (LFs) on progression from healthy to first cardiometabolic disease (FCMD), subsequently to cardiometabolic multimorbidity (CMM), and further to death is unclear.Methods and results We used data from the China Kadoorie Biobank of 461 047 adults aged 30–79 free of heart disease ...
Yizhen Hu, Canqing Yu, Ling Yang
exaly +4 more sources
Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999–2018
Cardiometabolic multimorbidity (co-existence of ≥1 cardiometabolic diseases) is increasingly common, while its prevalence in the U.S. is unknown. We utilized data from 10 National Health and Nutrition Examination Survey (NHANES) two-year cycles in U.S. adults from 1999 to 2018.
XunJie Cheng +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Chest, 2022
Although pulmonary function has been studied in relationship to individual cardiometabolic diseases, uncertainty persists about the difference in risk magnitudes of pulmonary function for these diseases and its association with cardiometabolic multimorbidity (CM).Does pulmonary function have different risk magnitudes for cardiometabolic diseases and CM?
Guochen Li, Yanqiang Lu, Yanan Qiao
exaly +3 more sources
Although pulmonary function has been studied in relationship to individual cardiometabolic diseases, uncertainty persists about the difference in risk magnitudes of pulmonary function for these diseases and its association with cardiometabolic multimorbidity (CM).Does pulmonary function have different risk magnitudes for cardiometabolic diseases and CM?
Guochen Li, Yanqiang Lu, Yanan Qiao
exaly +3 more sources
Cardiometabolic multimorbidity, genetic risk and dementia
Alzheimer's & Dementia, 2022AbstractBackgroundThe extent to which multiple cardiovascular and metabolic co‐morbidity and genetic factors combine or interact to increase dementia risk is unknown.MethodWe analysed 435 105 participants from the UK Biobank prospective cohort of European ancestry, aged 40 to 72 years, without dementia at baseline (2006‐2010), followed until 2021.
Tai, Xin You +7 more
openaire +2 more sources
BackgroundResearch has demonstrated that sarcopenia and visceral obesity are significant risk factors for chronic disease in middle-aged and older adults. However, the relationship between sarcopenia, the cardiac metabolic index (CMI), a novel measure of visceral obesity, and cardiometabolic multimorbidity (CMM) remains unclear.
Chuyang Lin, Yazhi Yang
exaly +4 more sources
BackgroundCardiometabolic multimorbidity (CMM) and aging are increasing public health concerns. This prospective study used UK Biobank cohort to investigate the relationship between biological aging and the trajectory of CMM to dementia and mortality.MethodsCMM is the coexistence of at least two cardiometabolic diseases (CMD), including stroke ...
Yu Jia, Zhi Wan, Dongze Li
exaly +4 more sources
Accelerated biological aging elevates the risk of cardiometabolic multimorbidity and mortality
Nature Cardiovascular ResearchAssociations of biological aging with the development and mortality of cardiometabolic multimorbidity (CMM) remain unclear. Here we conducted a multistate analysis in 341,159 adults of the UK Biobank. CMM was defined as the coexistence of two or three cardiometabolic diseases (CMDs), including type 2 diabetes, ischemic heart disease and stroke ...
Meijie Jiang +9 more
openaire +2 more sources

